Search Results
Search for other papers by Fabio V Comim in
Google Scholar
PubMed
Search for other papers by Kate Hardy in
Google Scholar
PubMed
Search for other papers by Jane Robinson in
Google Scholar
PubMed
Search for other papers by Stephen Franks in
Google Scholar
PubMed
polycystic ovaries ( Webber et al . 2003 , 2007 , Stubbs et al . 2007 ), these findings support the concept that aberrant follicle development in PCOS is programmed by exposure of the ovary to excess androgen during foetal life. Declaration of interest
Laboratory of Animal Nutrition,
Laboratory of Animal Breeding, Department of Animal Science, Agricultural University of Athens, 75, Iera odos, 11855 Athens, Greece
Search for other papers by S E Chadio in
Google Scholar
PubMed
Laboratory of Animal Nutrition,
Laboratory of Animal Breeding, Department of Animal Science, Agricultural University of Athens, 75, Iera odos, 11855 Athens, Greece
Search for other papers by B Kotsampasi in
Google Scholar
PubMed
Laboratory of Animal Nutrition,
Laboratory of Animal Breeding, Department of Animal Science, Agricultural University of Athens, 75, Iera odos, 11855 Athens, Greece
Search for other papers by G Papadomichelakis in
Google Scholar
PubMed
Laboratory of Animal Nutrition,
Laboratory of Animal Breeding, Department of Animal Science, Agricultural University of Athens, 75, Iera odos, 11855 Athens, Greece
Search for other papers by S Deligeorgis in
Google Scholar
PubMed
Laboratory of Animal Nutrition,
Laboratory of Animal Breeding, Department of Animal Science, Agricultural University of Athens, 75, Iera odos, 11855 Athens, Greece
Search for other papers by D Kalogiannis in
Google Scholar
PubMed
Laboratory of Animal Nutrition,
Laboratory of Animal Breeding, Department of Animal Science, Agricultural University of Athens, 75, Iera odos, 11855 Athens, Greece
Search for other papers by I Menegatos in
Google Scholar
PubMed
Laboratory of Animal Nutrition,
Laboratory of Animal Breeding, Department of Animal Science, Agricultural University of Athens, 75, Iera odos, 11855 Athens, Greece
Search for other papers by G Zervas in
Google Scholar
PubMed
Introduction A series of experimental and epidemiological studies had led to the fetal programming hypothesis, which implies that adverse environmental factors, acting in utero program the development of fetal tissues, producing
The ‘973’ National Basic Research Program of China, Changchun University of Chinese Medicine, Changchun, Jilin, People’s Republic of China
Search for other papers by Hao Wu in
Google Scholar
PubMed
Search for other papers by Junduo Wu in
Google Scholar
PubMed
Search for other papers by Shengzhu Zhou in
Google Scholar
PubMed
Search for other papers by Wenlin Huang in
Google Scholar
PubMed
Search for other papers by Ying Li in
Google Scholar
PubMed
Search for other papers by Huan Zhang in
Google Scholar
PubMed
Search for other papers by Junnan Wang in
Google Scholar
PubMed
Search for other papers by Ye Jia in
Google Scholar
PubMed
interest that could be perceived as prejudicing the impartiality of the research reported. Funding This work was supported in part by the National Natural Science Foundation of China (81600573) and Norman Bethune Program of Jilin University (2015438
Université Paris-Sud, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, France
Search for other papers by Anne-Lise Lecoq in
Google Scholar
PubMed
Search for other papers by Philippe Zizzari in
Google Scholar
PubMed
Université Paris-Sud, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, France
Search for other papers by Mirella Hage in
Google Scholar
PubMed
Search for other papers by Lyvianne Decourtye in
Google Scholar
PubMed
Search for other papers by Clovis Adam in
Google Scholar
PubMed
Université Paris-Sud, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, France
Search for other papers by Say Viengchareun in
Google Scholar
PubMed
Search for other papers by Johannes D Veldhuis in
Google Scholar
PubMed
Search for other papers by Valérie Geoffroy in
Google Scholar
PubMed
Université Paris-Sud, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, France
Search for other papers by Marc Lombès in
Google Scholar
PubMed
Search for other papers by Virginie Tolle in
Google Scholar
PubMed
Search for other papers by Anne Guillou in
Google Scholar
PubMed
Search for other papers by Auli Karhu in
Google Scholar
PubMed
Search for other papers by Laurent Kappeler in
Google Scholar
PubMed
Université Paris-Sud, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, France
Assistance Publique-Hôpitaux de Paris, Service d’Endocrinologie et des Maladies de la Reproduction, Hôpital Bicêtre, Le Kremlin Bicêtre, France
Search for other papers by Philippe Chanson in
Google Scholar
PubMed
Université Paris-Sud, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, France
Assistance Publique-Hôpitaux de Paris, Service d’Endocrinologie et des Maladies de la Reproduction, Hôpital Bicêtre, Le Kremlin Bicêtre, France
Search for other papers by Peter Kamenický in
Google Scholar
PubMed
VECTOR M.O.M. Immunodetection Kit FMK-2201 (Vector Laboratories, Eurobio) and the Dako Biotin Blocking System (X0590, Dako). Slides were incubated with a rabbit anti-GH antibody 1:20,000 (AFP5641801, NIDDK, National Hormone and Peptide Program
Search for other papers by L Johnsen in
Google Scholar
PubMed
Search for other papers by A H Kongsted in
Google Scholar
PubMed
Search for other papers by M O Nielsen in
Google Scholar
PubMed
exposures during fetal life with altered body functions and health outcomes later in life is often referred to as fetal metabolic programing (FMP). Experience from developing countries undergoing rapid economic transition indicates that individuals who have
Search for other papers by Kazunari Nohara in
Google Scholar
PubMed
Search for other papers by Suhuan Liu in
Google Scholar
PubMed
Search for other papers by Matthew S Meyers in
Google Scholar
PubMed
Search for other papers by Aurélie Waget in
Google Scholar
PubMed
Search for other papers by Mathieu Ferron in
Google Scholar
PubMed
Search for other papers by Gérard Karsenty in
Google Scholar
PubMed
Search for other papers by Rémy Burcelin in
Google Scholar
PubMed
Division of Endocrinology, Division of Endocrinology, Department of Genetics and Development, INSERM U1048, Metabolism and Molecular Medicine and Comprehensive Center on Obesity, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
Search for other papers by Franck Mauvais-Jarvis in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females of reproductive age and is believed to have a developmental origin in which maternal and fetal androgen excess during pregnancy programs both the
School of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, China
Search for other papers by Bo He in
Google Scholar
PubMed
Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, China
Search for other papers by Yinxian Wen in
Google Scholar
PubMed
Search for other papers by Shuwei Hu in
Google Scholar
PubMed
Search for other papers by Guihua Wang in
Google Scholar
PubMed
Search for other papers by Wen Hu in
Google Scholar
PubMed
Search for other papers by Jacques Magdalou in
Google Scholar
PubMed
Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, China
Search for other papers by Liaobin Chen in
Google Scholar
PubMed
Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, China
Search for other papers by Hui Wang in
Google Scholar
PubMed
have demonstrated that PCE can lead to fetal overexposure to maternal glucocorticoids and hypothalamic-pituitary-adrenal (HPA) axis-associated neuroendocrine metabolic programming alterations, resulting in the increased susceptibility of adult offspring
Search for other papers by Rob H P Hilgers in
Google Scholar
PubMed
Search for other papers by Suzanne Oparil in
Google Scholar
PubMed
Search for other papers by Wout Wouters in
Google Scholar
PubMed
Search for other papers by Herjan J T Coelingh Bennink in
Google Scholar
PubMed
This study compared ex vivo relaxing responses to the naturally occurring human hormone estetrol (E4) vs 17β-estradiol (E2) in eight different vascular beds. Arteries were mounted in a myograph, contracted with either phenylephrine or serotonin, and cumulative concentration-response curves (CRCs) to E4 and E2 (0.1–100 μmol/l) were constructed. In all arteries tested, E4 had lower potency than E2, although the differential effect was less in larger than smaller arteries. In uterine arteries, the nonselective estrogen receptor (ER) blocker ICI 182 780 (1 μmol/l) caused a significant rightward shift in the CRC to both E4 and E2, indicating that the relaxation responses were ER dependent. Pharmacological blockade of nitric oxide (NO) synthases by N ω-nitro-l-arginine methyl ester (l-NAME) blunted E2-mediated but not E4-mediated relaxing responses, while inhibition of prostaglandins and endothelium-dependent hyperpolarization did not alter relaxation to either E4 or E2 in uterine arteries. Combined blockade of NO release and action with l-NAME and the soluble guanylate cyclase (sGC) inhibitor ODQ resulted in greater inhibition of the relaxation response to E4 compared with E2 in uterine arteries. Endothelium denudation inhibited responses to both E4 and E2, while E4 and E2 concentration-dependently blocked smooth muscle cell Ca2 + entry in K+-depolarized and Ca2 +-depleted uterine arteries. In conclusion, E4 relaxes precontracted rat arteries in an artery-specific fashion. In uterine arteries, E4-induced relaxations are partially mediated via an endothelium-dependent mechanism involving ERs, sGC, and inhibition of smooth muscle cell Ca2 + entry, but not NO synthases or endothelium-dependent hyperpolarization.
Departments of, Cellular Physiological Chemistry, Fixed Prosthodontics, International Research Center for Molecular Science in Tooth and Bone Diseases (Global COE program), Institute of Cellular and System Medicine, Department of Hard Tissue Engineering (Pharmacology), Graduate School
Departments of, Cellular Physiological Chemistry, Fixed Prosthodontics, International Research Center for Molecular Science in Tooth and Bone Diseases (Global COE program), Institute of Cellular and System Medicine, Department of Hard Tissue Engineering (Pharmacology), Graduate School
Search for other papers by Chalida Nakalekha in
Google Scholar
PubMed
Departments of, Cellular Physiological Chemistry, Fixed Prosthodontics, International Research Center for Molecular Science in Tooth and Bone Diseases (Global COE program), Institute of Cellular and System Medicine, Department of Hard Tissue Engineering (Pharmacology), Graduate School
Search for other papers by Chieko Yokoyama in
Google Scholar
PubMed
Search for other papers by Hiroyuki Miura in
Google Scholar
PubMed
Departments of, Cellular Physiological Chemistry, Fixed Prosthodontics, International Research Center for Molecular Science in Tooth and Bone Diseases (Global COE program), Institute of Cellular and System Medicine, Department of Hard Tissue Engineering (Pharmacology), Graduate School
Search for other papers by Neil Alles in
Google Scholar
PubMed
Departments of, Cellular Physiological Chemistry, Fixed Prosthodontics, International Research Center for Molecular Science in Tooth and Bone Diseases (Global COE program), Institute of Cellular and System Medicine, Department of Hard Tissue Engineering (Pharmacology), Graduate School
Search for other papers by Kazuhiro Aoki in
Google Scholar
PubMed
Search for other papers by Keiichi Ohya in
Google Scholar
PubMed
Departments of, Cellular Physiological Chemistry, Fixed Prosthodontics, International Research Center for Molecular Science in Tooth and Bone Diseases (Global COE program), Institute of Cellular and System Medicine, Department of Hard Tissue Engineering (Pharmacology), Graduate School
Search for other papers by Ikuo Morita in
Google Scholar
PubMed
Prostaglandins (PGs) are key regulatory factors that affect bone metabolism. Prostaglandin E2 (PGE2) regulates bone resorption and bone formation. Prostacyclin (PGI2) is one of the major products derived from arachidonic acid by the action of cyclooxygenase and PGI2 synthase (PGIS). Unlike PGE2, there are few reports about the role of PGI2 in bone regulation. Therefore, we investigated the potential effect of PGI2 on bone metabolism. We used PGIS knockout (PGIS−/−), PGIS heterozygous (PGIS+ /−), and wild-type mice to investigate the role of PGI2. Notably, PGIS−/− mice gradually displayed an increase in trabecular bone mass in adolescence. Adult PGIS−/− mice showed an increase in trabecular bone volume/tissue volume. Histomorphometric analysis showed that PGIS−/− mice displayed increases in both bone formation and bone resorption parameters. Levels of serum osteocalcin and C-telopeptides were increased in adult PGIS−/− mice. Furthermore, the increased bone mass patterns were rescued in PGIS−/tg mice. In conclusion, adult PGIS−/− mice displayed an overall increase in the levels of both bone formation and bone resorption parameters, which suggests that PGI2 deficiency accelerates high bone turnover activity with a greater increase in bone mass in aging. These results indicated that PGI2 may contribute to the maintenance of normal bone mass and micro-architecture in mice in age-dependent manner. Our findings demonstrate for the first time that PGI2 is involved in bone metabolism in vivo.
Endocrinologh and Reproductive Physiology Graduate Training Program, University of Wisconsin, Madison, Wisconsin, USA
Search for other papers by Virginia L Pszczolkowski in
Google Scholar
PubMed
Vita Plus Corporation, Madison, Wisconsin, USA
Search for other papers by Meghan K Connelly in
Google Scholar
PubMed
Endocrinologh and Reproductive Physiology Graduate Training Program, University of Wisconsin, Madison, Wisconsin, USA
Search for other papers by Adam D Beard in
Google Scholar
PubMed
Search for other papers by Amara D Benn in
Google Scholar
PubMed
Endocrinologh and Reproductive Physiology Graduate Training Program, University of Wisconsin, Madison, Wisconsin, USA
Search for other papers by Jimena Laporta in
Google Scholar
PubMed
Endocrinologh and Reproductive Physiology Graduate Training Program, University of Wisconsin, Madison, Wisconsin, USA
Search for other papers by Laura L Hernandez in
Google Scholar
PubMed
Endocrinologh and Reproductive Physiology Graduate Training Program, University of Wisconsin, Madison, Wisconsin, USA
Search for other papers by Sebastian I Arriola Apelo in
Google Scholar
PubMed
Energy partitioning in lactating cows affects milk production, feed efficiency, and body reserves, with the latter having health implications for the transition into the following lactation. One molecule likely involved in the regulation of energy partitioning is serotonin. The objective of this experiment was to explore how increasing circulating serotonin, by intravenous infusion of the serotonin precursor 5-hydroxytryptophan (5-HTP), affects metabolic responses to a glucose challenge in midlactation cows as a means to manipulate energy partitioning. We intravenously infused Holstein cows with 5-HTP (1 mg/kg bodyweight dissolved in saline, n = 11) or saline alone as control (n = 9) over 1 h/day for 3 days. Cows were fasted overnight on day 2. On day 3, fasted cows were given an intravenous bolus of glucose (0.092 g/kg bodyweight). Blood samples were collected for the following 120 min for metabolic and hormonal analysis. Infusion of 5-HTP elevated circulating concentrations of serotonin and free fatty acids, reduced the concentration of insulin and amino acids, and did not affect the concentration of glucose and glucagon before the glucose challenge. Surrogate insulin sensitivity indices indicated improved insulin sensitivity in 5-HTP cows, but due to the unique metabolism of lactating ruminants, these index changes may instead reflect effects in insulin-independent glucose disposal, like milk synthesis. Challenging 5-HTP-treated cows with a glucose bolus reduced the insulin spike and blunted the decrease in free fatty acids, compared to saline cows, without changing glucose dynamics. Overall, these results suggest that serotonin stimulates insulin-independent glucose disposal, requiring less insulin to maintain normoglycemia.
